Amneal Pharmaceuticals (AMRX) PT Raised to $9 at Truist Securities
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $17.27 -2.21%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Truist Securities analyst Les Sulewski raised the price target on Amneal Pharmaceuticals (: AMRX) to $9.00 (from $7.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Nihon Kohden Corp (6849:JP) PT Lowered to JPY1,400 at Nomura/Instinet
- Omada Health Inc (OMDA) PT Raised to $32 at Citizens on Strong Revenue Growth
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
